Adamantiades-Behçet’s Disease

Initial Contributions of Adamantiades and Behçet....Pages 3-5
A Historical Review of Adamantiades-behçet’s Disease....Pages 7-14
Multicentre Clinical Registries....Pages 17-24
Epidemiology of Behçet’s Disease in Asian Countries and Japan....Pages 25-29
Recent Epidemiological Data on Behçet’s Disease in Iran....Pages 31-36
Prevalence of Behçet’s Disease among Iraqis....Pages 37-41
Current Epidemiological Data from the German Registry of Adamantiades-Behçet’s Disease....Pages 43-48
Heterogenity of Clinical Manifestations in Behçet’s Disease among Different Ethnic Groups....Pages 49-51
Behçet’s Disease in Patients of German and Turkish Origin — A Comparative Study....Pages 53-58
Influence of Sex on Patients with Behçet’s Disease in Korea....Pages 59-63
The Influence of Gender on the Frequency of Clinical Symptoms in Behçet’s Disease....Pages 65-66
The Influence of Gender on the Severity and the Outcome of Ocular Lesions in Behçet’s Disease....Pages 67-71
The Implications of Nonaphthous Beginning of Behçet’s Disease....Pages 73-76
Clinical Manifestations and Course of 200 Japanese Patients with Behçet’s Disease....Pages 77-79
Clinical Presentation of Behçet’s Disease in Internal Medicine....Pages 81-82
The Change of Clinical Manifestations of Patients with Behçet’s Disease in Japan....Pages 83-84
Chronology of Clinical Manifestations in Behçet’s Disease....Pages 85-89
General Aspects and Clinical Manifestations of 100 Iraqi Patients with Behçet’s Disease....Pages 91-94
The Prevalence of Behçet’s Syndrome and Its Neurological Complications in Hertfordshire, U.K.....Pages 95-97
Clinical and Genetic Characteristics of Late-Onset Behçet’s Disease....Pages 99-101
The Importance of the Manifestations Besides the Ones Included in International Criteria for Behçet’s Disease....Pages 105-108
Influence of Pathergy Test on the Accuracy of Different Diagnosis Criteria for Behçet’s Disease....Pages 109-112
Measuring Health Related Quality of Life....Pages 113-122
Univariate and Multivariate Analyses Comparing Demographic, Genetic, Clinical, and Serological Risk Factors for Severe Adamantiades-Behçet’s Disease....Pages 123-126
Is Long Term Observation of Patients with Recurrent Aphthous Stomatitis Necessary?....Pages 127-130
Acetylator Phenotype in Behçet’s Disease....Pages 131-138
HLA Antigen, Severity and Acetylator Phenotype in Behçet’s Disease Patients with Non-Relative Parents....Pages 139-142
Risk Factors of Neuro-Behçet....Pages 143-146
Association of HLA-B51 with Clinical Expression of Behçet’s Disease....Pages 147-148
The Behçet’s Disease Activity Index....Pages 149-151
Development of Clinical Activity Form for Korean Patients with Behçet’s Disease....Pages 153-156
Living with Behçet’s Disease....Pages 157-158
Pathogenesis of Adamantiades-Behçet’s disease....Pages 161-171
Immunopathogenesis and Prevention of Uveitis with the Behçet’s Disease-Specific Peptide Linked to Cholera Toxin B....Pages 173-180
The Role of Infectious Agents in the Pathogenesis of Behçet’s Disease....Pages 181-183
Detection of Microbial DNA in Skin Lesions from Patients with Behçet’s Disease....Pages 185-190
Association of Mycoplasma fermentans with Adamantiades-Behçeťs Disease....Pages 191-194
Antimicrobial Activity of Synthetic Human CAP18 Peptides to Streptococcus sanguis Isolated from Patients with Behçeťs Disease....Pages 195-200
Anti- Saccharomyces cerevisiae Antibodies....Pages 201-204
The Human Genome Project: What We have Learnt about the MHC Region on Chromosome 6 and Its Potential to Behçet’s Disease....Pages 207-211
Comparison of Proteome Map Between Sera of Patients with Behçet’s Disease and Controls....Pages 213-215
HLA Typing for Class I and Class II Antigens in Iraqi Patients with Behçet’s Disease (Sporadic and Familial Cases)....Pages 217-220
Strong Association of MIC-A * 009 of Extracellular Domains and MIC-A * A6 of Transmembrane Domain in Korean Patients with Behçeťs Disease....Pages 221-224
MICA Transmembrane Region Polymorphism and HLA B51 in Tunisian Behçeťs Disease Patients....Pages 225-228
HLA-B51 Frequency in Iranian Patients with Behçet’s Disease....Pages 229-230
Frequency of HLA in Patients with Behçet’s Disease and Association with Occlusive Retinal Vasculitis....Pages 231-233
The ICAM1469*E is Associated with Susceptibility to Ocular Lesions and Vasculitis in Korean Patients with Behçet’s Disease....Pages 235-236
Chemokines in Behçet’s Disease, a Field to Be Explored as a Potential Basis for Therapy....Pages 239-243
Expression of CCR5 in Behçet’s Disease....Pages 245-247
Immunophenotype and Th1/Th2 Cytokines in Patients with Adamantiades-Behçet’s Disease....Pages 249-253
Cytokine Production of Peripheral Blood Mononuclear Cells Stimulated with Streptococcus Sanguis Antigen in Patients with Behçet’s Disease....Pages 255-260
Serum Levels of Soluble TNF-α Receptor-II (P75), Circulating γδ T-Cells and Adamantiades-behçet’s Disease Activity....Pages 261-265
T-γδ Receptor Restriction in Peripheral Lymphocytes of Patients with Behçet’s Disease....Pages 267-268
Lymphocyte Subsets and Activated Neutrophils in Iraqi Patients with Behçet’s Disease....Pages 269-272
L-Selectin Expression on Leukocytes of Patients with Behçet’s Disease....Pages 273-278
Autoimmunity to S-Antigen and Retinal Vasculitis in Patients with Behçet’s Disease....Pages 279-281
Nerve Growth Factor in Behçet’s Disease....Pages 283-285
Low Serum Mannose-binding Lectin Levels in Behçet’s Disease....Pages 287-289
ISBD Basic Research Perspectives....Pages 293-299
Complex Aphthosis: Evaluation for Behçet’s Disease?....Pages 303-310
Complex Aphthosis....Pages 311-316
Comparison of Oral Aphthae in Behçet’s Disease and Idiopathic Recurrent Aphthous Stomatitis....Pages 317-320
Bipolar Aphthosis. A Forme Fruste of Behçet’s Disease....Pages 321-322
The Effect of Smoking on the Clinical Features of Adamantiades-Behçet’s Disease....Pages 323-327
Muco-Cutaneous Lesions of Behçet’s Disease....Pages 329-330
Dilsen’s Pathergy Test in Behçet’s Disease: Positive Correlation with Clinical Manifestations....Pages 331-332
Is Behçet’s Disease a Kobner Positive Disorder?....Pages 333-335
Extensive Pyoderma Gangrenosum-Like Lesion in Two Cases of Behçe’s Disease, Responding Only to Cyclosporin....Pages 337-338
A Case of SAPHO Syndrome with Pyoderma Gangrenosum and Inflammatory Bowel Disease Masquerading as Behçe’s Disease....Pages 339-341
Cytokine Expression within Mucocutaneous Lesions of Behçe‘s Disease: Involvement of Proinflammatory and Th1 Cytokines....Pages 343-346
Origin and Outcome of Macular Edema in Behçet’s Disease....Pages 349-353
Fluorescein Angiography and Optical Coherence Tomography in Ocular Behçet’s Disease....Pages 355-360
Cells of the Vitreous Body in Behçet’s Disease....Pages 361-363
Ocular Lesions Other than Behçet’s Disease in Behçet’s Disease-Affected Patients....Pages 365-368
Neuro-Behçet’s Disease (Isolated Cerebral Thrombophlebitis Excluded)....Pages 371-376
The Prevalence of Headache in Behçet’s Syndrome....Pages 377-379
Adamantiades-Behcet’s Disease and Elevated Intracranial Pressure in a 12 Year Old Turkish Girl....Pages 381-382
Sensory Symptoms in Behçet’s Syndrome....Pages 383-384
Immunohistological Studies in Neuro-Behçet’s Disease....Pages 385-387
Soluble Fas Ligand Levels in Cerebrospinal Fluid in Neuro-Behçet’s Disease....Pages 389-391
Behçet’s Disease with Vascular Involvement: The Contribution of Anticardiolipin Antibodies and Thrombomodulin....Pages 395-398
Arterial Wall Characteristics in Patients with Adamantiades-Behçet’s Disease....Pages 399-404
The Influence of Plasma Fibrinogen and Serum Ferrum on Blood Viscosity in Adamantiades-Behçet’s Disease....Pages 405-412
Does Hyperhomocysteinemia Increase the Risk of Thrombosis in Behçet’s Disease?....Pages 413-417
Pulmonary Artery Involvement in Behçet’s Disease....Pages 419-422
Cardiac Manifestation in Four Patients with Adamantiades-Behçet’s Disease....Pages 423-426
Quantitative Evaluation of Microvessels in Behçet’s Disease....Pages 427-433
 18 -F-FDG-Positron Emission Tomography for Diagnosis of Large Vessel Arteritis in Behçet’s Disease....Pages 435-436
Spontaneous Platelet Aggregation in Patients with Behçet’s Disease by Using Laser-Light Scattering Aggregometer....Pages 437-441
New Perspectives of Imaging Techniques for Diagnosis of Organ Manifestations in Behçet’s Disease....Pages 445-448
The Comparison of Ankylosing Spondylitis in Behçet’s Disease and Normal Population....Pages 449-453
Gastro-Intestinal Manifestations of Behçet’s Disease....Pages 455-457
Gastrointestinal Disease in Behcet’s Disease....Pages 459-464
Clinical Features of Behçet’s Disease Patients with Epididymitis....Pages 465-469
Tonsillectomy and Behçet’s Disease....Pages 471-472
Destructive Sinusopathy and Middle Ear Involvement in Behçet’s Syndrome....Pages 473-475
Urine Abnormalities in Behçet’s Disease....Pages 477-478
Behçet’s Syndrome: From Aetiology to Treatment....Pages 481-486
Treatment of Ocular Manifestations of Behçet’s Disease....Pages 487-491
The Influence of the Delay of Aggressive Treatment on the Vision and its Outcome in Behçet’s Disease....Pages 493-494
The Clinical Outcome and Treatment in Behçet’s Disease with Deep Vein Thrombosis....Pages 495-501
The Use of Interferon-α in Behçet’s Disease — Review of the Literature and Possible Mechanisms of Action....Pages 503-509
Interferon alfa-2a in the Treatment of Ocular Adamantiades-Behçet’s Disease....Pages 511-519
Human Recombinant Interferon-α2a (rhIFNα2a) for the Treatment of Behçet’s Disease with Sight-Threatening Retinal Vasculitis....Pages 521-523
Behçet’s Disease: Visual Acuity after 5 Years in Patients with Alpha-Interferon Treatment....Pages 525-528
Multifocal ERG Changes in Patients with Ocular Behçet’s Disease During Therapy with Interferon alpha 2a....Pages 529-532
Influence of Interferon-alpha on Lymphocyte Subpopulations in Behçet’s Disease....Pages 533-535
Interferon alpha 2a in IRPB-derived Peptide-induced EAU — Part I....Pages 537-540
A Case of Behçet’s Disease with Pathergy Reaction at Interferon Injection Site....Pages 541-543
Current and Future Use of Anti-TNF Agents in the Treatment of Autoimmune, Inflammatory Disorders....Pages 545-549
Successful Long-term Treatment of Refractory Adamantiades-Behçet’ss Disease (ABD) with Infliximab: Report of Two Patients....Pages 551-555
The Effect of Anti-Tumour Necrosis Factor alpha (Infliximab) on Sight-Threatening Uveitis in a Patient with Behçet’s Disease....Pages 557-559
Antitumor Necrosis Factor Monoclonal Antibody Therapy in a Woman with Severe Adamantiades-Behçet’s Disease....Pages 561-562
Efficacy of Corticosteroids and Cyclosporin in the Treatment of Retinal Vasculitis in Patients with Behçet’s Disease....Pages 563-565
Enhancement of Transmucosal Permeation of Cyclosporine by Benzalkonium Chloride....Pages 567-570
Azathioprine and Low Dose Pulse Cyclophosphamide in Severe Ocular Lesions of Behçet’ss Disease....Pages 571-573
Low Dose MTX for Progressive Neuro-Behçet’s Disease....Pages 575-578
High Dose Methotrexate for Ocular Lesions of Behçet’s Disease....Pages 579-584
Therapeutic Effect of Thalidomide through Cytokine and Chemokine Regulation in Herpes Simplex Virus-induced Behçet’s Disease-Like Animal Model....Pages 585-589
Pentoxifylline Use for Behçet’s Disease....Pages 591-594
Cataract Surgery in Behçet’s Disease Patients....Pages 595-597
Do Metal Surgical Staples Induce Post-Surgical Intestinal Ulcer in Behçet’s Disease?....Pages 599-600
Clinicans, Scientists and Patients....Pages 603-604
Hopes of Patients with Behçet’s Disease in Japan Towards Researchers and the Relationship between Patients and Medical Staff Concerning Social Work....Pages 605-608
Jordan Friends of Behçet’s Disease Patients Society....Pages 609-611
The Relationship Between Patient Groups and Physicians from a UK Support Group Perspective....Pages 613-617
“Living with Behçet’ - A Young Patients’ Group....Pages 619-620
Private Practice Offices Serve as Centers for Adamantiades-Behçet’s Disease....Pages 621-626